All Johns Hopkins Medicine articles
-
News
Surprise find in study of environmental bacteria could advance search for better antibiotics
In what they labeled a “surprising” finding, researchers studying bacteria from freshwater lakes and soil say they have determined a protein’s essential role in maintaining the germ’s shape.
-
News
NIH funds consortium to accelerate development of new TB treatments
A new consortium has been awarded a five-year, $31 million grant from the National Institutes of Health’s National Institute of Allergy and Infectious Diseases to accelerate the development of faster, more effective treatment regimens for tuberculosis.
-
News
Regular vaccine boosts may help people who are immunocompromised fight Covid-19
New research finds booster doses of bivalent vaccines given every three to six months helps maintain a person’s ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5.
-
News
Black individuals more likely to experience inequities in early diagnosis of Lyme disease
A new study reveals that black patients are more likely to have advanced stages of Lyme disease when clinically diagnosed and also experience a longer time before receiving antibiotic treatment for the condition.
-
News
COVID-19 vaccination reduces severity and mortality after breakthrough infections
Among individuals recently infected with SARS-CoV-2, those who were fully vaccinated had lower concentrations of almost all inflammation markers (cytokines and chemokines) than those who were unvaccinated in the short-term and long-term after symptomatic SARS-CoV-2 infection.
-
News
Test tube immune system IDs protein candidates for HIV vaccine
Scientists have developed a technique to find protein fragments that best stimulate the immune system to recognize and attack the virus.
-
News
Change in genetics of SARS-CoV-2 evolved to counter weakness caused by the virus’s initial mutation
Researchers at Johns Hopkins Medicine say their new studies suggest that the first pandemic-accelerating mutation in the SARS-CoV-2 virus, which causes COVID-19, evolved as a way to correct vulnerabilities caused by the mutation that started the SARS-CoV-2 pandemic.